However, BRAF mutated pathway via p13k/AKT, which promotes survival and cell cycle entry in melanoma cells, is another mechanism. PTEN mutation, though uncommon, inhibits AKT-p13k pathways [23]. The gene discussed is AKT1; the disease is melanoma.